Craig Foster, MD
Anesthesiology · Willimantic, CTNPI 1962451211
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $530 and has fallen 91.3% since, to $46 in 2025. Among anesthesiology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 54 payments — averaging $21.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$224
- Ironwood Pharmaceuticals, Inc$213
- Boehringer Ingelheim$147
- Takeda Pharmaceuticals U.S.A., Inc.$129
- Johnson & Johnson$99
- Braintree Laboratories, Inc.$60
- plus $301 from 12 others
What the payments were for
- Food & beverage$1,173100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,173 in reported general payments places this provider in the 90th percentile of 664 anesthesiology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 113 | $1,638 |
| Morphine Sulfate ErMorphine Sulfate | 22 | $426 |
| Tramadol Hcl | 87 | $418 |
| Pregabalin | 21 | $281 |
| Cyclobenzaprine Hcl | 15 | $92 |
| Carisoprodol | 11 | $56 |
| Oxycodone Hcl | 11 | $38 |
| Diazepam | 17 | $20 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Willimantic
- Divya Mangala Kestur RajasekharWillimantic$2K
- Brian KingWillimantic$1K
- Zeev KainNew Haven$273K
- Alison ConsidineNew Haven$82K
- Sanjay SinhaHartford$42K
- William RosenblattNew Haven$40K
- Paul HeerdtNew Haven$36K
- Antonio PazBrookfield$27K
- Honghui FengOld Saybrook$20K
- Prakash PatelNew Haven$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.